Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.sjbs.2021.03.007 http://scihub22266oqcxt.onion/10.1016/j.sjbs.2021.03.007 33746537!7955801!33746537     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Saudi+J+Biol+Sci 2021 ; 28 (6): 3433-3437 Nephropedia Template TP {{tp|p=33746537|t=2021. Validation and performance comparison of two SARS-CoV-2 IgG/IgM rapid tests |pdf=|usr=}}{{33746537}} gab.com Text Validation and performance comparison of two SARS-CoV-2 IgG/IgM rapid tests JO: Saudi J Biol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33746537 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a disease called COVID-19. COVID-19 is primarily diagnosed using molecular techniques mainly real-time reverse transcriptase PCR. Reliable and accurate serologic assays for COVID-19, are an important tool for surveillance and epidemiologic studies. In this study, the IgG/IgM Rapid Test Cassette and the Prima COVID-19 IgG/IgM Rapid Test for the detection of SARS-CoV-2 antibodies in blood, serum and plasma samples collected from patients up to 48 days after symptom onset in Saudi Arabia were validated. Overall, both tests showed poor performance and cannot be utilised for COVID-19 diagnosis as a point of care test or to determine seroprevalence. Twit Text FOAVip Validation and performance comparison of two SARS-CoV-2 IgG/IgM rapid tests ????Saudi J Biol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33746537 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33746537 #FOAvip English Wikipedia <ref>{{Cite pmid|33746537}}</ref> Validation and performance comparison of two SARS-CoV-2 IgG/IgM rapid tests #MMPMID33746537 Al Awaji NN; Ahmedah HT; Alsaady IM; Bawaked RA; Alraey MA; Alasiri AA; Alfaifi AM; Alshehri HA; Alserihi R; Yasin EB Saudi J Biol Sci 2021[Jun]; 28 (6): 3433-3437 PMID33746537show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a disease called COVID-19. COVID-19 is primarily diagnosed using molecular techniques mainly real-time reverse transcriptase PCR. Reliable and accurate serologic assays for COVID-19, are an important tool for surveillance and epidemiologic studies. In this study, the IgG/IgM Rapid Test Cassette and the Prima COVID-19 IgG/IgM Rapid Test for the detection of SARS-CoV-2 antibodies in blood, serum and plasma samples collected from patients up to 48 days after symptom onset in Saudi Arabia were validated. Overall, both tests showed poor performance and cannot be utilised for COVID-19 diagnosis as a point of care test or to determine seroprevalence. äValidation and performance comparison of two SARS-CoV-2 IgG/IgM rapid (epmc).pdf DeepDyve Pubget Overpricing